Asherman's syndrome other diagnostic studies

Revision as of 17:22, 1 August 2022 by Saud Khan (talk | contribs)
Jump to navigation Jump to search

Asherman's syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Asherman's syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Asherman's syndrome other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Asherman's syndrome other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Asherman's syndrome other diagnostic studies

CDC on Asherman's syndrome other diagnostic studies

Asherman's syndrome other diagnostic studies in the news

Blogs on Asherman's syndrome other diagnostic studies

Directions to Hospitals Treating Asherman's syndrome

Risk calculators and risk factors for Asherman's syndrome other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor-In-Chief: Saud Khan M.D.

Overview

Hysteroscopy remains the gold standard. MRI may be needed when there is total obliteration of the uterine cavity.

References


Template:WikiDoc Sources